Serum biomarkers in the metabolic dysfunction-associated steatotic liver fibrosis diagnosis in children
Background. The COVID-19 epidemic and the war in Ukraine have led to a significant increase in the number of children suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). One of the unresolved problems associated with MASLD is the identification of individuals at risk of...
Saved in:
Main Authors: | Yu.M. Stepanov, N.Yu. Zavhorodnia, I.A. Klenina, O.M. Tatarchuk, O.P. Petishko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2024-12-01
|
Series: | Gastroenterologìa |
Subjects: | |
Online Access: | https://gastro.zaslavsky.com.ua/index.php/journal/article/view/640 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01) -
Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Zhifeng Gao, et al.
Published: (2025-01-01) -
Association of high-sensitivity C-reactive protein with hepatic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
by: Yunfei Wu, et al.
Published: (2025-02-01) -
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01) -
Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
by: Fan Zhang, et al.
Published: (2025-01-01)